Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Adma Biologics Inc (NASDAQ: ADMA) was $20.32 for the day, up 2.63% from the previous closing price of $19.80. In other words, the price has increased by $2.63 from its previous closing price. On the day, 2.34 million shares were traded. ADMA stock price reached its highest trading level at $20.5299 during the session, while it also had its lowest trading level at $19.79.
Ratios:
Our analysis of ADMA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 46.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 43.72. For the most recent quarter (mrq), Quick Ratio is recorded 2.90 and its Current Ratio is at 5.97. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.23.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 19 ’25 when Grossman Adam S sold 21,000 shares for $18.92 per share. The transaction valued at 397,320 led to the insider holds 2,061,850 shares of the business.
Grossman Adam S bought 84,000 shares of ADMA for $1,571,640 on Mar 19 ’25. On Nov 22 ’24, another insider, Tade Brad L., who serves as the CFO and Treasurer of the company, sold 15,000 shares for $21.15 each. As a result, the insider received 317,250 and left with 199,433 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4828336640 and an Enterprise Value of 4807307776. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.11, and their Forward P/E ratio for the next fiscal year is 20.59. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.32 while its Price-to-Book (P/B) ratio in mrq is 13.78. Its current Enterprise Value per Revenue stands at 11.273 whereas that against EBITDA is 32.719.
Stock Price History:
The Beta on a monthly basis for ADMA is 0.54, which has changed by 2.126154 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $5.89. The 50-Day Moving Average of the stock is 20.24%, while the 200-Day Moving Average is calculated to be 22.44%.
Shares Statistics:
ADMA traded an average of 2.66M shares per day over the past three months and 3913910 shares per day over the past ten days. A total of 236.62M shares are outstanding, with a floating share count of 229.28M. Insiders hold about 3.51% of the company’s shares, while institutions hold 86.22% stake in the company. Shares short for ADMA as of 1740700800 were 14225572 with a Short Ratio of 5.36, compared to 1738281600 on 13176851. Therefore, it implies a Short% of Shares Outstanding of 14225572 and a Short% of Float of 6.1899999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
